EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endogenous anti-Ebola virus GP 1,2 antibodies interfere with detection of secreted glycoprotein in the blood of EVD patients

Patrick T Tshita, Aurélie Ploquin, John Misasi, Bobo N Bazola, Samuel M Shamamba, Hadar Marcus, Ange Y Mubiala, Francis M Ntumba, Saidou Milua iD, Courtney Tucker, Eddy Kinganda-Lusamaki iD, Emmanuel Lokilo iD und 13 weitere

Journal of Virology · 2026

DOI: 10.1128/jvi.01414-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Patrick T Tshita und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo. Hauptthemen laut MEDLINE: Ebolavirus, Antibodies, Viral, Hemorrhagic Fever, Ebola, Viral Envelope Proteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: African Academy of Sciences, FIC NIH HHS, Fogarty International Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ebola disease (EBOD) is a highly infectious disease with severe hemorrhagic symptoms. It is caused by orthoebolaviruses , which include the Ebola virus ( Orthoebolavirus zairense ) (EBOV) causing Ebola virus disease (EVD), the most lethal EBOD to humans. Through co-transcriptional polymerase stuttering and subsequent proteolytic processing, its GP gene produces multiple protein products, including secreted glycoprotein (sGP) and structural membrane-associated trimeric GP 1,2 . Although sGP is known to circulate in the blood, its physiological significance in disease pathology remains speculative. We quantified sGP using enzyme-linked immunosorbent assay (ELISA) in 36 acute human EVD cases from the 10th and 11th EVD outbreaks in the Democratic Republic of the Congo (DRC) using single-time-point biobanked samples. We detected and quantified sGP in four patients with strong GP gene transcription (GP Ct < 25), as evidence of viral replication, but with no endogenous anti-EBOV GP 1,2 IgG. However, sGP was not quantified in patients with lower GP transcription (Ct > 25), regardless of their anti-EBOV GP 1,2 IgG results. While two patients, MAM179 and MAM271, had notably strong GP transcription (Ct < 25), their high amounts of endogenous anti-EBOV GP 1,2 IgG might have interfered with detection by the assay detection antibody, a human anti-EBOV GP 1,2 /sGP IgG. Furthermore, the addition of sera containing anti-EBOV GP 1,2 IgG reduced the binding between sGP and anti-EBOV GP 1,2 /sGP used as detection antibodies. This suggested that the level of sGP in circulation is strongly linked to the intensity of GP transcription. Additionally, circulating sGP in this context would form complexes with anti-GP 1,2 antibodies, hence hindering additional antibody binding for detection. IMPORTANCE Insight into the mechanism of immune function by the Ebola virus secreted glycoprotein (sGP) in humans is essential for better understanding viral pathogenesis, immune protection, and immune evasion strategies. Research utilizing samples from patients who are infected with or have survived infection with the Ebola virus offers an unparalleled opportunity to determine the immunological significance of sGP. This research evaluates, in acutely infected patients from Ebola virus disease outbreaks, the role of EBOV sGP in modulating antibody responses directed against viral entry glycoprotein. By elucidating how sGP influences antibody-mediated immunity, the study advances our understanding of a conserved immune-evasion mechanism shared across all orthoebolaviruses. These investigations are valuable resources for designing more efficacious vaccines, therapies, and biomarkers for monitoring Ebola virus diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EbolavirusAntibodies, ViralHemorrhagic Fever, EbolaViral Envelope ProteinsGlycoproteinsHumansDemocratic Republic of the CongoEnzyme-Linked Immunosorbent AssayDisease Outbreaks

Stichwörter der Autor:innen

Ebola virusantibodydiagnosticsglycoproteinsimmunotherapyorthoebolavirus

Substanzen

Antibodies, ViralViral Envelope ProteinsGlycoproteins

Autor:innen und Institutionen

  • Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
  • Institut Superieur des Techniques Medicales Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Microbiology Service, Department of Medical Biology, Faculty of Medicine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Global Medical Affairs, Ridgeback Biotherapeutics, Miami, Florida, USA.

ORCID-Profile: Saidou Milua, Eddy Kinganda-Lusamaki, Emmanuel Lokilo, Aziza Amuri, Placide Mbala-Kingebeni, Sabue Mulangu, Jean-Jacques Muyembe-Tamfum, Nancy J Sullivan, Dacquin M Kasumba

Förderung

  • African Academy of Sciences
  • FIC NIH HHS
  • Fogarty International Center

Zitieren

APA

Tshita, P. T., Ploquin, A., Misasi, J., Bazola, B. N., Shamamba, S. M., Marcus, H., Mubiala, A. Y., Ntumba, F. M., Milua, S., Tucker, C., Kinganda-Lusamaki, E., Lokilo, E., Lumbembe, R., Amuri, A., Bayoka, N., Suangi, A., Kahusu, C. M., Mbilizi, I. M., Tshiani-Mbaya, O., …, & Kasumba, D. M. (2026). Endogenous anti-Ebola virus GP 1,2 antibodies interfere with detection of secreted glycoprotein in the blood of EVD patients. Journal of Virology. https://doi.org/10.1128/jvi.01414-26

Vancouver

Tshita PT, Ploquin A, Misasi J, Bazola BN, Shamamba SM, Marcus H, et al. Endogenous anti-Ebola virus GP 1,2 antibodies interfere with detection of secreted glycoprotein in the blood of EVD patients. Journal of Virology. 2026. doi:10.1128/jvi.01414-26

BibTeX
@article{Tshita2026,
  author = {Tshita, Patrick T and Ploquin, Aurélie and Misasi, John and Bazola, Bobo N and Shamamba, Samuel M and Marcus, Hadar and Mubiala, Ange Y and Ntumba, Francis M and Milua, Saidou and Tucker, Courtney and Kinganda-Lusamaki, Eddy and Lokilo, Emmanuel and Lumbembe, Raphael and Amuri, Aziza and Bayoka, Naomie and Suangi, Anthony and Kahusu, Christian M and Mbilizi, Ilombe Myriam and Tshiani-Mbaya, Olivier and Kandolo, Denis K and Mbala-Kingebeni, Placide and Mulangu, Sabue and Muyembe-Tamfum, Jean-Jacques and Sullivan, Nancy J and Kasumba, Dacquin M},
  title = {Endogenous anti-Ebola virus GP 1,2 antibodies interfere with detection of secreted glycoprotein in the blood of EVD patients},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01414-26}
}
Kostenlos starten →